Morgan Stanley holds $18 target on XPeng shares, sees upside By Investing.com
© Reuters. On Wednesday, Morgan Stanley reiterated its confidence in XPeng Inc. (NYSE:), sustaining an Chubby ranking and a $18.00 ...
Tag: shares
Lennox International EVP Gary Bedard sells shares worth over $875k By Investing.com
© Reuters. Gary S. Bedard, the Govt Vice President and President of Residence Consolation Options at Lennox Worldwide Inc. (NYSE:), ...
Ingredion executive sells residual shares worth $18 By Investing.com
© Reuters. WESTCHESTER, IL – Ingredion Integrated (NYSE:), a number one world ingredient options supplier, has reported a minor transaction ...
Tata Sons to sell 23.4 mn TCS shares worth Rs 9,362 crore in block deal
Tata Sons is about to divest a 0.65 per cent stake in its flagship Tata Consultancy Companies (TCS) on ...
Mondi shares upgraded to buy with GBP16.50 stock target By Investing.com
© Reuters. On Thursday, Mondi Plc. (LON::LB) (OTC: MONDY), a global packaging and paper group, acquired an improve in inventory ...
SpiceJet finalises lease agreements for 10 aircraft, shares surge over 9%
Shares of low-cost air service SpiceJet surged over 9 per cent on Thursday as the corporate stated that it has ...
Asia markets news: Shares slip, yen firms as Japan GDP data revised up
Asian markets information: Share markets adopted Wall Avenue decrease on Monday whereas the greenback seemed susceptible forward of a studying ...
Electrovaya shares get boost from Roth/MKM, cites ‘broad range’ of products By Investing.com
© Reuters. On Wednesday, Electrovaya Inc. (NASDAQ:ELVA) obtained a optimistic outlook from Roth/MKM because the agency began protection on the ...
Zomato block deal: 17.64 crore shares may change hands; Antfin Singapore expected sell stake
Zomato block deal: Zomato shares might be within the limelight as we speak, March 6, as studies recommend round 17.64 ...
Morgan Stanley sets $40 target on Kyverna Therapeutics shares By Investing.com
© Reuters. On Monday, Morgan Stanley initiated protection on Kyverna Therapeutics Inc (NASDAQ:KYTX), a biopharmaceutical firm, with an Chubby ranking ...
